Investigating how a protein related to Alzheimer's affects cell energy and waste management

Relationships between APP and Mitochondria

NIH-funded research University of Kansas Medical Center · NIH-11009578

This study is looking at how a protein called APP helps clean up damaged parts of cells to keep them healthy and produce energy, which is important for understanding problems in Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kansas Medical Center NIH-funded
Lab location1 site (Kansas City, United States)
Project IDNIH-11009578 on NIH RePORTER

What this research studies

This research explores the role of amyloid precursor protein (APP) in the process of mitophagy, which is the removal of damaged mitochondria from cells, and its impact on energy production in cells. The researchers hypothesize that APP interacts with specific proteins to facilitate this process and that a reduction in APP can lead to mitochondrial dysfunction, which is a significant issue in Alzheimer's disease. By studying these interactions, the research aims to uncover how APP influences cellular health and energy metabolism, potentially leading to new insights into Alzheimer's disease mechanisms.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those exhibiting early signs of cognitive decline.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve mitochondrial function and energy metabolism in patients with Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding the relationship between APP and mitochondrial function, indicating that this area of study has potential for significant advancements.

Where this research is happening

Kansas City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.